Saurabh Saha - Feb 2, 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Executive Officer, Director
Signature
/s/ Marella Thorell, attorney-in-fact
Stock symbol
CNTA
Transactions as of
Feb 2, 2022
Transactions value $
$48,700
Form type
4
Date filed
2/4/2022, 07:30 AM
Previous filing
Feb 3, 2022
Next filing
Jun 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Purchase $48.7K +5K +21.74% $9.74 28K Feb 2, 2022 By trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.65 to $9.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.